Bacil Pharma BSE
7.75 00.00 (1.04%)
Bacil Pharma share price as of last closing was 7.75 on . As on date, the market capitalization of the company is Rs. 4.78 Crores and the book value of the same is Rs 0.78 Crores. As per NSE data, in last traded details the quantity of shares traded for Bacil Pharma were . For the last 1 year period, Bacil Pharma share price saw 1-year high of 9.68 and 1-year low of 3.85. If you would have invested in Bacil Pharma share,... based on its share price your 1-year return on same would be 33.11%, on a 3-year investment period the return would be 211.11% and on a 5 year investment period the return would be 155.35%. In the financial year -, Bacil Pharma registered a net income of 0.00 Cr. The company’s EPS stood at 0.00 while P/E Ratio stood at 0.00. While, analysing Share Price of a company is crucial, it is equally important to look at the Stock Performance, Fundamental Analysis, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.
Markets Today
High | 8.13 |
Open at | 8.13 |
Volumes | 37 |
Lower Circuit | 2100.00 |
Low | 7.37 |
Prev Close | 7.75 |
Avg Price | 2205.85 |
Upper Circuit | 2400.00 |
Last Traded Details
Quantity | 92,923 |
Time | 13:46:05 |
Historical Performance
1-Year High | 9.68 |
3-Year High | 9.68 |
5-Year High | 9.68 |
1-Year Low | 3.85 |
3-Year Low | 2.22 |
5-Year Low | 1.57 |
1-Year Performance Indicator
Company Valuation
Market Cap (₹ Cr.) | 4.78 |
Book Value (₹) | 0.78 |
Face Value (₹) | 10.00 |
P/E ratio | 0.00 |
Dividend Yield | 0.0 % |
Income Statements
Financial Year | FY - |
All Expenditure (Cr) | 0.00 |
Operating Profit (Cr) | 0.00 |
EBIDTA (Cr) | 0.00 |
Profit Before Tax (Cr) | 0.00 |
Tax (Cr) | 0.00 |
Net Income (Cr) | 0.00 |
EPS (Cr) | 0.00 |
DPS (Cr) | 0.00 |
In Short term
In Long term
1 Week | 19.59% |
1 Month | 54.67% |
3 Months | 29.51% |
6 Months | 9.73% |
9 Months | 100.49% |
1 Year | 33.11% |
2 Years | 10.48% |
3 Years | 211.11% |
4 Years | 238.33% |
5 Years | 155.35% |
Bacil Pharma share price as of today is Rs. . The company has a market capitalization of Rs. 4.78 with a P/E ratio of 0.00. Over the past 1 year, Bacil Pharma’s share price has moved by 33.11% while the 5-year performance of the stock stands at 155.35%. You’d also be interested to know that Bacil Pharma's share price has a 1-year low of ₹ 3.85 and a 1-year high of ₹ 9.68.
The Bacil Pharma share hit a 1-year low of Rs. 3.85 and a 1-year high of Rs. 9.68. The current market capitalization of Bacil Pharma is Rs. 4.78. While past performance does not guarantee future performance, the past 1-year return of Bacil Pharma share was 33.11% while the 5-year return was 155.35%.
Bacil Pharma share price has moved by 33.11% in the past 1 year. During the same time, the stock hit a 1-year high of Rs. 9.68 and a 1-year low of Rs. 3.85. As far as the long-term trend is concerned, the 5-year performance of Bacil Pharma share stands at 155.35%
Bacil Pharma has a market capitalization of Rs. 4.78 as of today, while the share price stands at . The market cap has moved by 33.11% in the past year and 155.35% in the past 5 years.
As a stock investor, you’d be interested in knowing that Bacil Pharma share price has a P/E ratio of 0.00 as of today. Along with the P/E ratio, the book value of Bacil Pharma’s stock is Rs. 0.78
Domestic Institutional Investors (DIIs) have a share in Bacil Pharma whereas Foreign Institutional Investors (FIIs) hold . The split between DIIs and FIIs is a crucial metric that stock investors track to gauge the market sentiment around the stock. The company’s promoters own of Bacil Pharma while non-promoters have a stake.
You can buy Bacil Pharma shares using the Dhan Trading App or Web Trading Platform. Follow these steps to get started:
If you have little money and want to buy Bacil Pharma stocks,Margin Trading Facility (MTF) is just the thing you need! MTF allows you to buy more with less. In fact, you can buy up to 4x more, which means you pay 25% and Dhan pays 75% for buying Bacil Pharma stocks.